415 related articles for article (PubMed ID: 24176648)
21. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune encephalitis: recent updates and emerging challenges.
Ramanathan S; Mohammad SS; Brilot F; Dale RC
J Clin Neurosci; 2014 May; 21(5):722-30. PubMed ID: 24246947
[TBL] [Abstract][Full Text] [Related]
23. [Autoimmune encephalitis and its related-disorders].
Yoneda M
Rinsho Shinkeigaku; 2013; 53(11):1059-62. PubMed ID: 24291879
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune encephalitis.
Newman MP; Blum S; Wong RC; Scott JG; Prain K; Wilson RJ; Gillis D
Intern Med J; 2016 Feb; 46(2):148-57. PubMed ID: 26899887
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
26. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
27. Assessing the clinical features of LGI1 antibody encephalitis.
Zhao PP; Zhang Y; Gao L; Sun L
Acta Neurol Belg; 2016 Mar; 116(1):109-12. PubMed ID: 26220774
[No Abstract] [Full Text] [Related]
28. The immunobiology of autoimmune encephalitides.
Alexopoulos H; Dalakas MC
J Autoimmun; 2019 Nov; 104():102339. PubMed ID: 31611142
[TBL] [Abstract][Full Text] [Related]
29. Frequent hemianesthesia as initial symptom of limbic encephalitis associated with LGI1 antibodies.
Gong J; Zhang Y; Wang F; Huang Y; Zhang W
Neurol Sci; 2015 Oct; 36(10):1953-5. PubMed ID: 26094002
[No Abstract] [Full Text] [Related]
30. A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions.
Sato M; Kishida D; Miyazaki D; Sekijima Y
Intern Med; 2019 Jan; 58(2):287-291. PubMed ID: 30146575
[TBL] [Abstract][Full Text] [Related]
31. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.
Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L
J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
[TBL] [Abstract][Full Text] [Related]
33. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
34. The neuropsychological spectrum of anti-LGI1 antibody mediated autoimmune encephalitis.
Griffith SP; Malpas CB; Alpitsis R; O'Brien TJ; Monif M
J Neuroimmunol; 2020 Aug; 345():577271. PubMed ID: 32480239
[TBL] [Abstract][Full Text] [Related]
35. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
36. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
37. Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review.
Li X; Yuan J; Liu L; Hu W
BMC Neurol; 2019 Feb; 19(1):19. PubMed ID: 30732585
[TBL] [Abstract][Full Text] [Related]
38. Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.
Brown JW; Martin PJ; Thorpe JW; Michell AW; Coles AJ; Cox AL; Vincent A; Zandi MS
J Neuroimmunol; 2014 Jun; 271(1-2):66-8. PubMed ID: 24703099
[TBL] [Abstract][Full Text] [Related]
39. The Treatment and Follow-Up of Anti-LGI1 Limbic Encephalitis.
Yu J; Yu X; Fang S; Zhang Y; Lin W
Eur Neurol; 2016; 75(1-2):5-11. PubMed ID: 26694143
[TBL] [Abstract][Full Text] [Related]
40. Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability.
Kornau HC; Kreye J; Stumpf A; Fukata Y; Parthier D; Sammons RP; Imbrosci B; Kurpjuweit S; Kowski AB; Fukata M; Prüss H; Schmitz D
Ann Neurol; 2020 Mar; 87(3):405-418. PubMed ID: 31900946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
